PMI Stock Picard Medical (PMI, $2.07) was a top gainer for penny stocks yesterday, jumping +18.29% to $2.07 per share
at Tickeron.com
Loading...
A.I.dvisor analyzed 216 other stocks in the Medical/Nursing Services Industry and found that of them () are in an Uptrend while of them () are in a Downtrend.
Momentum Indicator for PMI turns positive, indicating new upward trend
PMI saw its Momentum Indicator move above the 0 level on January 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 1 similar instances where the indicator turned positive. In of the 1 cases, the stock moved higher in the following days. The odds of a move higher are at .
Technical Analysis (Indicators)
Bullish Trend Analysis
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PMI broke above its upper Bollinger Band on February 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PMI entered a downward trend on January 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.762) is normal, around the industry mean (11.546). P/E Ratio (0.000) is within average values for comparable stocks, (38.420). PMI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.636). PMI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (29.674) is also within normal values, averaging (38.937).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Advertisement